Atlas Infectious Disease Practice

Welcome to Atlas Infectious Disease Practice, where your health and the well-being of the community are our top priorities. We take pride in our critical role in safeguarding public health by providing a comprehensive range of services focused on the diagnosis, treatment, management, and prevention of infectious diseases. Our dedicated team of physicians and healthcare professionals are committed to delivering expert care and guidance. Explore the services and affiliations that make us a trusted partner in your health journey

Mission Statement

At Atlas Infectious Disease Practice, we are dedicated to providing exceptional and compassionate care for patients in Palm Beach County and the surrounding areas. Our practice specializes in treating a wide range of infectious diseases, including HIV, tuberculosis, hepatitis, sexually transmitted infections, respiratory illnesses, and more.

As the leading infectious disease doctors near you, we utilize cutting-edge diagnostics and innovative treatments to enhance health outcomes and improve the quality of life for our patients. Our holistic approach focuses not only on treating current infections but also on preventing future ones. We are committed to personalized care, providing education and empowering our patients to actively manage their health.

Conveniently located in Palm Beach County, Atlas Infectious Disease Practice is your trusted partner in managing infectious diseases. Whether you’re seeking proactive Prevention or expert care from the best Infectious Disease Doctors near you, our team is here to help.

.

Services

Services Provided

Hospital Consultation

Office Consultation

Immigration Exams

Travel Consultation

Telemedicine

Yellow Fever Vaccine

HIV medicine

Sexually transmitted infection

employee health

IV infusion

Latest news

Stay Informed

Clinical Implications, Study Takeaways of Gepotidacin For Uncomplicated UTIs

Earlier this week, the FDA approved GSK’s antibiotic, gepotidacin (Blujepa). The treatment is indicated for uncomplicated urinary tract infections (UTIs) in female patients aged at least 12 years and...

New approach could treat anthrax beyond the ‘point of no return’

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once the disease has progressed beyond the “point of no return” after...

HHS Plans a Major Downsize, Restructuring of Federal Health Agencies

The Health and Human Services (HHS) department announced yesterday it is planning on a major shakeup, reshuffling of the agencies and laying off thousands of workers. According to a statement by HHS...

Pandemic Public Health Policy and Trust: Did We Lose the Latter Through the Former’s Actions?

In the second installment of our interview with Robert Hopkins Jr, MD, the medical director of the National Foundation for Infectious Diseases (NFID), he discusses some of the takeaways in how public...

Investigational Monoclonal Antibody for Chronic Hepatitis D Treatment Begins Clinical Trial

Redwood City, Calif-based Bluejay Therapeutics, announced yesterday it had dosed the first patient in their clinical trial, which will evaluate their monoclonal antibody, brelovitug (also known as...

Research finds potential ‘molecular mimics’ behind COVID-induced autoimmune disease

COVID infection has been linked to higher risk of autoimmune disorders, including rheumatoid arthritis and type 1 diabetes. But why the virus might cause the body’s immune system to go haywire...

Measles Outbreak Expands to 4 States

This photograph depicts a child who was infected with the measles during a US outbreak in 2024. The child’s cheek shows the characteristic rash associated with this viral infection. Image credit: CDC/...

The Importance to Address and Help Visceral Adiposity in HIV Patients

Theratechnologies has received FDA approval for its supplemental Biologics License Application (sBLA) for EGRIFTA WR (Tesamorelin F8), a newly formulated treatment designed to reduce excess visceral...

Clinical Insights on HIV-Associated Visceral Fat Following FDA Approval of Tesamorelin F8

The FDA has approved Theratechnologies’ supplemental Biologics License Application (sBLA) for EGRIFTA WR (Tesamorelin F8), a new formulation designed to treat excess visceral abdominal fat in adults...

FDA Approves F8 Formulation of Theratechnologies’ Tesamorelin for HIV-Associated Lipodystrophy

The FDA has approved Theratechnologies’ supplemental Biologics License Application (sBLA) for EGRIFTA WR (Tesamorelin F8), a treatment for excess visceral abdominal fat in adults with HIV-associated...

Variability in Primary Care Telehealth Delivery Methods Across Chronic Conditions

This cross-sectional study examines chronic conditions that are more or less likely to be managed in...

HIV Viral Suppression With Long-Acting Antiretroviral Therapy

This study uses electronic medical record data to compare 48-week viral load outcomes after starting...

Unintentional Fentanyl Use Detected in Hair

This study assessed hair samples to detect fentanyl exposure among people with or at risk of HIV...

Comparative Bleeding Risk in Older Patients With HIV and Atrial Fibrillation Receiving Oral Anticoagulants

This cohort study compares the bleeding risks among warfarin, rivaroxaban, and apixaban users in a...

Hepatitis C Virus Screening in Pregnant and Nonpregnant Women After Universal Screening Guidelines

This study examines whether hepatitis C virus screening differs among pregnant and nonpregnant...

Changes to CDC’s Website Threaten Patients, Public Health

This Medical News article discusses the impact of President Donald Trump’s executive orders on the...

IAS-USA Recommendations: Antiretrovirals for Treatment and Prevention of HIV in Adults

This Special Communication from the International Antiviral Society–USA provides updated 2024...

Advances in Treatment and Prevention of HIV

Advances in antiretroviral therapy (ART) has led to HIV being a manageable and preventable condition...

Jarisch-Herxheimer Reaction After Benzathine Penicillin G Treatment for Early Syphilis

This secondary analysis of a randomized clinical trial assesses the incidence of Jarisch-Herxheimer...

Elective Surgery for People With HIV With Low CD4 Count

This case report describes a man in his 60s with hypertension, deep vein thrombosis, and a recent...

Communicable disease threats report, 22-28 March 2025, week 13

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22-28 March 2025...

Communicable disease threats report, 15 – 21 March 2025, week 12

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 15 – 21...

Accepted insurances

Schedule appointment

We Are Dedicated To Your Health!

Better Care Starts With Us!

Testimonials

What Our Patients Say About Us!